Indeed, an experimental model of RA revealed that NADPH oxidase is responsible for increased endothelial oxidative stress, and an in vitro administration of diphenylene iodonium chloride, an inhibitor of NAD(P)H oxidase activity, reduced the production of superoxide anions [41]. The gene discussed is FMO5; the disease is rheumatoid arthritis.